Myelophthisic anemia

Summary

Myelophthisic anemia (MONDO:0005868) is a disease. A subtype of aplastic anemia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	myelophthisic anemia
Mondo ID	MONDO:0005868
EFO	EFO:0007388
MeSH	D000750
DOID	DOID:2354
ICD-10-CM	D61.82
SNOMED CT	2694001
UMLS	C0002890
MedGen	1529
GARD	0024247
Is cancer (heuristic)	no

Also known as: anaemia LEUKOERYTHROBLASTIC · anemia LEUKOERYTHROBLASTIC · leukoerythroblastic reaction

Disease family

This is a subtype of aplastic anemia. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › hematologic disorder › anemia › aplastic anemia › myelophthisic anemia

Related subtypes (3): inherited aplastic anemia, idiopathic aplastic anemia, acquired aplastic anemia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.